{
  "trial_id": "NCT00268892",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, body weight, height, baseline prostate-specific antigen (PSA) levels, baseline liver function tests, baseline vital signs, medical history, prior treatments for prostate cancer, duration of prostate cancer diagnosis, baseline testosterone levels.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Body Weight",
          "body weight"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Time since Prostate Cancer Diagnosis",
          "duration of prostate cancer diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body Mass Index",
        "Curative Intent",
        "Gleason Score",
        "Stage of Prostate Cancer"
      ],
      "remaining_candidate_features": [
        "Age",
        "height",
        "baseline prostate-specific antigen (PSA) levels",
        "baseline liver function tests",
        "baseline vital signs",
        "medical history",
        "prior treatments for prostate cancer",
        "baseline testosterone levels"
      ]
    },
    "processed-gen-response": "Age, sex, race, body weight, height, baseline prostate-specific antigen (PSA) levels, baseline liver function tests, baseline vital signs, medical history, prior treatments for prostate cancer, duration of prostate cancer diagnosis, baseline testosterone levels."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Body Weight, Vital Signs, Liver Function Tests, Duration of Prostate Cancer, Previous Treatments, Baseline PSA Levels, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Body Weight",
          "Body Weight"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Time since Prostate Cancer Diagnosis",
          "Duration of Prostate Cancer"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Body Mass Index",
        "Curative Intent",
        "Gleason Score",
        "Stage of Prostate Cancer"
      ],
      "remaining_candidate_features": [
        "Age",
        "Region of Enrollment",
        "Vital Signs",
        "Liver Function Tests",
        "Previous Treatments",
        "Baseline PSA Levels"
      ]
    },
    "processed-gen-response": "Age, Sex: Male, Race/Ethnicity, Region of Enrollment, Body Weight, Vital Signs, Liver Function Tests, Duration of Prostate Cancer, Previous Treatments, Baseline PSA Levels"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Race/Ethnicity, Customized, Region of Enrollment, Prostate cancer diagnosis duration, Previous treatment for prostate cancer, PSA level, Gleason score, \n\n##Question:\n##Answer:",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Male",
          "Gender"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Body Weight",
          "Body Weight"
        ],
        [
          "Gleason Score",
          "Gleason score"
        ],
        [
          "Time since Prostate Cancer Diagnosis",
          "Prostate cancer diagnosis duration"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Body Mass Index",
        "Curative Intent",
        "Stage of Prostate Cancer"
      ],
      "remaining_candidate_features": [
        "Age",
        "Region of Enrollment",
        "Previous treatment for prostate cancer",
        "PSA level"
      ]
    },
    "processed-gen-response": "Age, Gender, Race/Ethnicity, Region of Enrollment, Prostate cancer diagnosis duration, Previous treatment for prostate cancer, PSA level, Gleason score, ##Question:"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), prostate-specific antigen (PSA) level, Gleason score, prostate cancer stage, duration of prostate cancer, previous prostate cancer treatments, medical history, concomitant medications, vital signs (heart rate, blood pressure, temperature), body weight, liver function tests (aspartate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Body Weight",
          "body weight"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Gleason Score",
          "Gleason score"
        ],
        [
          "Stage of Prostate Cancer",
          "prostate cancer stage"
        ],
        [
          "Time since Prostate Cancer Diagnosis",
          "duration of prostate cancer"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Curative Intent"
      ],
      "remaining_candidate_features": [
        "Age",
        "ethnicity",
        "prostate-specific antigen (PSA) level",
        "previous prostate cancer treatments",
        "medical history",
        "concomitant medications",
        "vital signs (heart rate, blood pressure, temperature)",
        "liver function tests (aspartate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin)"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), prostate-specific antigen (PSA) level, Gleason score, prostate cancer stage, duration of prostate cancer, previous prostate cancer treatments, medical history, concomitant medications, vital signs (heart rate, blood pressure, temperature), body weight, liver function tests (aspartate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin)."
  }
}